Published in BMC Cancer on July 12, 2006
Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing. Virchows Arch (2014) 1.93
Sarcomatoid carcinoma of colon: extremely poor prognosis. J Korean Surg Soc (2011) 0.96
Carcinosarcoma in the cecum. Gut Liver (2012) 0.94
Carcinosarcoma on ascending colon found by bowel perforation: a case report. J Korean Soc Coloproctol (2010) 0.90
Rectal metastasis of prostate cancer: about a case. J Clin Med Res (2010) 0.83
The significance of the site of origin in primary peritoneal carcinosarcoma: case report and literature review. Ecancermedicalscience (2013) 0.76
Uterine Carcinosarcoma in a 2-year-old Female Wistar Hannover GALAS Rat. J Toxicol Pathol (2011) 0.76
Carcinosarcoma of the Sigmoid Colon: Report of a Case. Case Rep Gastroenterol (2010) 0.75
Carcinosarcoma of the Rectum: Report of a Rare Colorectal Malignancy and Review of the Literature. Case Rep Surg (2015) 0.75
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med (2004) 71.08
Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med (2005) 6.22
Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol (1996) 2.20
Carcinosarcomas: current perspectives and an historical review of nosological concepts. Semin Diagn Pathol (1993) 2.00
Analysis by comparative genomic hybridization of epithelial and spindle cell components in sarcomatoid carcinoma and carcinosarcoma: histogenetic aspects. J Pathol (1999) 1.32
Skin metastasis from the spindle cell component in rectal carcinosarcoma. Hepatogastroenterology (2001) 1.29
Carcinosarcoma of the rectosigmoid colon: report of a case. Surg Today (2003) 1.27
Sarcomatoid carcinomas (carcinosarcomas) of the gastrointestinal tract: a review. Semin Diagn Pathol (1993) 1.24
Carcinosarcoma of the colon. Report of a unique case with light and immunohistochemical studies. Cancer (1986) 1.21
Carcinosarcoma of the colon and spleen: a fleshy purple mass on colonoscopy. Dig Dis Sci (2001) 1.18
Carcinosarcoma of the breast: molecular-biological study for analysis of histogenesis. Hum Pathol (1998) 1.16
Sarcomatoid carcinoma of the colon: a case report with literature review. Tumori (2002) 1.12
Uterine carcinosarcoma is derived from a single stem cell: an in vitro study. Int J Cancer (1997) 1.10
Sarcomatoid carcinoma of the anorectal junction with neuroendocrine and rhabdomyoblastic features. Am J Surg Pathol (1995) 1.06
p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes. Cancer Res (1993) 1.05
Carcinosarcoma of the colon: report of a rare tumor. Pathol Res Pract (2003) 1.03
Sarcomatoid carcinoma of the colon: a case report. J Korean Med Sci (2001) 1.02
Sarcomatoid carcinoma of the colon. Report of the second case with immunohistochemical study. Pathol Res Pract (1996) 1.01
Carcinosarcoma of the colon: report of a case and review of the literature. J Gastroenterol (1998) 1.00
Sarcomatoid carcinoma of the descending colon--a histological, immunohistochemical and ultrastructural analysis. Acta Oncol (1998) 0.98
[Carcinosarcoma of the colon, one or two tumors?]. Pathologica (1997) 0.97
True carcinosarcoma of the colon. Case report. Langenbecks Arch Chir (1997) 0.95
Radiology-Pathology Conference: carcinosarcoma of the colon. Clin Imaging (2005) 0.95
Molecular evidence for the same clonal origin of both components of an adenosquamous Barrett carcinoma. Gastroenterology (2002) 0.91
Spindle and giant cell carcinoma of the colon. Histopathology (1997) 0.90
[Malignant tumors of the colon with two components (carcinosarcoma). Report of a case]. Ann Pathol (1995) 0.88
[Sarcomatoid carcinoma of the colon: report of a case and review of the literature]. Gastroenterol Clin Biol (2004) 0.88
Immunohistochemical profile and c-kit mutations in gastrointestinal stromal tumors. Pathol Res Pract (2005) 0.82
Video-assisted sleeve lobectomy for mucoepidermoid carcinoma of the left lower lobar bronchus: a case report. Chest (2002) 3.25
Plasma chromogranin a in patients with inflammatory bowel disease. Inflamm Bowel Dis (2009) 2.37
Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses. Clin Cancer Res (2009) 2.00
Banking together. A unified model of informed consent for biobanking. EMBO Rep (2008) 1.67
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors. Proc Natl Acad Sci U S A (2010) 1.55
Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients. J Clin Endocrinol Metab (2010) 1.53
Homing of peripherally injected bone marrow cells in rat after experimental myocardial injury. Haematologica (2003) 1.49
Molecular and immunohistochemical analysis of HER2/neu oncogene in synovial sarcoma. Hum Pathol (2003) 1.47
Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma. BMC Cancer (2009) 1.40
Survivin gene expression in early-stage non-small cell lung cancer. J Pathol (2003) 1.35
Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis. Am J Pathol (2010) 1.30
Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells. J Clin Invest (2013) 1.28
Up-regulation of focal adhesion kinase in non-small cell lung cancer. Lung Cancer (2006) 1.27
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer. J Exp Med (2011) 1.27
Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res (2006) 1.23
High incidence of benign testicular neoplasms diagnosed by ultrasound. J Urol (2003) 1.23
Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile. Mol Cancer (2008) 1.22
MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma. Liver Int (2012) 1.18
Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s. Cancer Cell (2012) 1.17
The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis. Mod Pathol (2012) 1.13
Quantitative PCR and HER2 testing in breast cancer: a technical and cost-effectiveness analysis. Am J Clin Pathol (2008) 1.12
Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J Clin Endocrinol Metab (2011) 1.11
Helicobacter pylori-negative Russell body gastritis: case report. World J Gastroenterol (2011) 1.07
Expression of heat shock protein 27 in human renal cell carcinoma. Proteomics (2004) 1.07
Survivin gene expression in chronic liver disease and hepatocellular carcinoma. Hepatogastroenterology (2008) 1.05
Complementary populations of human adipose CD34+ progenitor cells promote growth, angiogenesis, and metastasis of breast cancer. Cancer Res (2013) 1.05
SEL1L a multifaceted protein playing a role in tumor progression. J Cell Physiol (2006) 1.03
HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry. Clin Cancer Res (2003) 1.00
Schwann cell hamartoma: case report. BMC Gastroenterol (2011) 1.00
Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein. Cancer Res (2004) 0.99
Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker. Chest (2005) 0.97
Identification of potential therapeutic targets in malignant mesothelioma using cell-cycle gene expression analysis. Am J Pathol (2009) 0.96
The microRNA cluster C19MC is deregulated in parathyroid tumours. J Mol Endocrinol (2012) 0.95
Serum biomarkers of renal cell carcinoma assessed using a protein profiling approach based on ClinProt technique. Urology (2009) 0.95
The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats. J Cell Mol Med (2010) 0.95
Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia? Endocr Relat Cancer (2007) 0.95
Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation. Lab Invest (2002) 0.94
Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors. Breast Cancer Res (2014) 0.93
Role of Strain Rate in the Pathogenesis of Ventilator-Induced Lung Edema. Crit Care Med (2016) 0.93
MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma. Liver Int (2014) 0.93
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3. Am J Pathol (2010) 0.93
Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease. Crit Care Med (2004) 0.92
The multiple personality disorder phenotype(s) of circulating endothelial cells in cancer. Biochim Biophys Acta (2009) 0.92
HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions. Mod Pathol (2013) 0.92
Pirin inhibits cellular senescence in melanocytic cells. Am J Pathol (2011) 0.92
The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas. J Neuroimmunol (2013) 0.92
Regulation of lung cancer metastasis by Klf4-Numb-like signaling. Cancer Res (2013) 0.91
Protein kinase A regulatory subunits in human adipose tissue: decreased R2B expression and activity in adipocytes from obese subjects. Diabetes (2008) 0.91
Lymphomas of the bone: a pathological and clinical study of 54 cases. Int J Surg Pathol (2002) 0.91
Aberrant overexpression of the cell polarity module scribble in human cancer. Am J Pathol (2011) 0.91
The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells. Am J Pathol (2009) 0.90
Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues. J Proteome Res (2005) 0.90
Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy. Inflamm Bowel Dis (2013) 0.90
SEL1L expression in non-small cell lung cancer. Hum Pathol (2006) 0.89
Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease. Eur J Endocrinol (2004) 0.88
The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the "early" prepolycythemic phase of polycythemia vera and essential thrombocythemia. Am J Clin Pathol (2008) 0.88
Survivin expression in tuberous sclerosis complex cells. Mol Med (2007) 0.88
Transbronchial needle aspiration under direct endobronchial ultrasound guidance of PET-positive isolated mediastinal adenopathy in patients with previous malignancy. Surg Endosc (2008) 0.87
Correlation between Candida albicans biofilm formation and invasion of the invertebrate host Galleria mellonella. Future Microbiol (2014) 0.87
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors. J Proteomics (2012) 0.87
Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation. J Clin Endocrinol Metab (2009) 0.86
Circulating perivascular progenitors: a target of PDGFR inhibition. Int J Cancer (2011) 0.86
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE. Mol Biosyst (2012) 0.85
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt. Proteomics Clin Appl (2008) 0.85
Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease. Lab Invest (2010) 0.85
The oncofetal protein IMP3: a useful marker to predict poor clinical outcome in neuroendocrine tumors of the lung. J Thorac Oncol (2014) 0.84
SEL1L and squamous cell carcinoma of the esophagus. Clin Cancer Res (2004) 0.84
In vivo imaging of lymph node migration of MNP- and (111)In-labeled dendritic cells in a transgenic mouse model of breast cancer (MMTV-Ras). Mol Imaging Biol (2012) 0.84
Quantitative evaluation of the apoptosis regulating genes Survivin, Bcl-2 and Bax in inflammatory and malignant pleural lesions. Lung Cancer (2004) 0.84
miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo. Clin Sci (Lond) (2014) 0.84
Degradation of insulin-like growth factor-I receptor occurs via ubiquitin-proteasome pathway in human lung cancer cells. J Cell Physiol (2006) 0.84
Human malignant mesothelioma: molecular mechanisms of pathogenesis and progression. Int J Biochem Cell Biol (2006) 0.83
Potential advantages of cell administration on the inflammatory response compared to standard ACE inhibitor treatment in experimental myocardial infarction. J Transl Med (2008) 0.83
Left ventricular remodeling after experimental myocardial cryoinjury in rats. J Surg Res (2004) 0.83
Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma. J Clin Oncol (2003) 0.83